Clinical Trials on Brain Malignancies in Japan
Total 534 results
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaMedImmune LLCCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruiting
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Novartis PharmaceuticalsCompleted
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced MalignanciesJapan
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
AstraZenecaMedImmune LLCCompleted
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
AstraZenecaMedImmune LLCCompletedBlood Cancer | Advanced B Cell MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
Regeneron PharmaceuticalsRecruiting
-
Nagoya UniversityLife Science Institute, Inc.CompletedHypoxia-Ischemia, BrainJapan
-
Hokkaido University HospitalCompletedBrain MetastasisJapan
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
Japan Cardiovascular Research FoundationOtsuka Pharmaceutical Co., Ltd.CompletedNoncardioembolic Cerebral InfarctionJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
SanofiCompleted
-
AstraZenecaActive, not recruitingPart1: Advanced B-cell Malignancies | Part2: r/rCLL and r/rMCL | Part3: Untreated CLLJapan
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
HeadSense MedicalSuspendedStroke | Brain Injuries | Brain Neoplasms | Intracranial Hypertension | HydrocephalusJapan
-
Mitsubishi Tanabe Pharma CorporationKyowa Hakko Kogyo Co., Ltd.CompletedBrain Ischemia | Cerebral InfarctionJapan
-
Hyogo College of MedicineShionogiCompleted
-
Nara Medical UniversityCompletedHypertension | Brain InfarctionJapan
-
Nagoya UniversityAichi Gakuin UniversityUnknownMyocardial Infarction | Coronary Disease | Healthy | Cerebral InfarctionJapan
-
GlaxoSmithKlineWithdrawn
-
BayerJanssen Research & Development, LLCCompleted
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
Teijin Pharma LimitedCompleted
-
National Hospital Organization Osaka National HospitalNetwork for Clinical Stroke Trials; The BMS/Pfizer Japan Thrombosis Investigator...RecruitingIschemic Stroke | Atrial Fibrillation | AtherothrombosisJapan
-
BeiGeneActive, not recruitingMature B-cell MalignanciesJapan
-
NobelpharmaCompleted
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
Genzyme, a Sanofi CompanyCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingMature B-cell NeoplasmsJapan
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
-
Otsuka Pharmaceutical Co., Ltd.Completed